Профиль компании
- Фондовый код
- ABBV
- ISIN-код
- US00287Y1091
- Валюта
- US Dollar (USD)
- Дата IPO
- 2013-01-02

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat bl...